EXHIBIT 107.1

Calculation of Filing Fee Table

Form S-8

(Form Type)

Phathom Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered Securities

 

Security Type

Security Class Title

Fee Calculation Rule

Amount to be Registered (1)

Proposed Maximum Offering Price Per Share

Proposed Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Equity

Common Stock, par value $0.0001 per share

Rules 457(c) and 457(h)

1,415,000 shares (2)

$5.17 (3)

$7,315,550

$153.10 per $1,000,000

$1,120.02

Equity

Common Stock, par value $0.0001 per share

Rules 457(c) and 457(h)

1,085,000 shares (4)

$5.01 (5)

$5,435,850

$153.10 per $1,000,000

$832.23

Total Offering Amounts

$12,751,400

$1,952.25

Total Fee Offsets (6)

$0

Net Fee Due

$1,952.25

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also registers an indeterminate number of additional shares that may be issued pursuant to the above-named plans as the result of any future stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock.

(2) Represents 1,415,000 shares of common stock available for issuance under the Phathom Pharmaceuticals, Inc. 2025 Employment Inducement Incentive Award Plan (the “Inducement Plan”).

(3) This estimate is made pursuant to Rules 457(c) and 457(h) of the Securities Act solely for purposes of calculating the Registration fee. The Proposed Maximum Offering Price Per Share is $5.17 which is the average of the high and low prices for the Registrant’s common stock as reported on The Nasdaq Capital Market on April 3, 2025.

(4) Represents 1,085,000 shares of common stock subject to outstanding options under the Inducement Plan. To the extent outstanding options under the Inducement Plan are forfeited or lapse unexercised, the shares of common stock subject to such awards will be available for future issuance under the Inducement Plan. Each of the options has an exercise price per share equal to the closing price of the Registrant’s common stock on the grant date (April 3, 2025).

(5) This estimate is made pursuant to Rule 457 of the Securities Act solely for purposes of calculating the registration fee. The Proposed Maximum Offering Price Per Share is $5.01 per share, which is the weighted average exercise price of outstanding options granted under the Inducement Plan being registered.

(6) The Registrant does not have any fee offsets.